Histological spectrum and diagnostic challenges in endometrial carcinoma of the uterus


  • Teena V. Chandwani Department of Pathology Government Medical College and Hospital, Nagpur, Maharashtra, India
  • Dharitri M. Bhat Department of Pathology Government Medical College and Hospital, Nagpur, Maharashtra, India
  • Archana H. Deshpande Department of Pathology Government Medical College and Hospital, Nagpur, Maharashtra, India




Endometrial carcinoma of uterus, Endometrioid adenocarcinoma, Villoglandular adenocarcinoma, Serous adenocarcinoma, Architectural and nuclear grading


Background: Endometrial carcinoma is the most common type of malignancy of the uterine corpus accounting for 95% of all primary malignancies. Epidemiological studies have proved the role of unopposed estrogen as an important factor in pathogenesis of endometrial carcinoma. Pathologists play an important role not only in the histological confirmation of the diagnosis, but in subtyping, grading and staging of the tumor. Current study is undertaken to study the histological spectrum in endometrial carcinomas.

Methods: Present study includes histologically confirmed cases of endometrial carcinoma of uterine corpus over a period of 24 months (July2020 to June 2022) in a tertiary health care center in central India. After gross examination, and standard sectioning, all these tumors were subtyped on histology and grading, staging was done as per WHO and FIGO recommendations. In cases with diagnostic dispute and overlapping features, IHC markers were applied.

Results: Amongst total 30 confirmed cases of endometrial carcinoma, endometrioid type was most common (25) followed by villoglandular and serous type of adenocarcinoma. Architectural and nuclear grading was done in all cases. Staging could be done in hysterectomy specimens only. Difficulties encountered while grading and staging are discussed.

Conclusions: Endometrial carcinoma was the most common type of malignancy. Other types were villoglandular and serous adenocarcinoma. Various additional histological features were also observed. Grade I tumors were commonly seen. Depth of myometrial invasion was measured in hysterectomy specimens. Various diagnostic challenges encountered are discussed.


Zahida OA, Niaz M, Upadhyaya K. Study of malignant tumors of the uterine corpus, et al. Int J Reprod Contracept Obstet Gynecol. 2020;9(9):3843-6.

McMeekin DS, Yashar C, Campos SM, Zaino RJ. Corpus: epithelial tumors. in: principles and practice of gynecologic oncology (eds. Barakat RR, Berchuk A, Markman M, Randall M). 6th ed. Lippincott Williams & Wilkins;2013:661-714.

Setiawan VW, Yang HP, Pike MC, McCann SE, Yu H, Xiang YB et al. Type I and II endometrial cancers: have they different risk factors? J Clin Oncol. 2013;31:2607.

Yasuda M. Immunohistochemical characterization of Endometrial carcinomas: Endometrioid, serous and clear cell adenocarcinomas in association with genetic analysis. J Obstet Gynecol Res. 2014;40(12):2167-6.

Crum CP, Nucci MR, Granter SR, Howitt BE, Parast MM, Boyd TK, Theonia. editors Diagnostic Gynaecologic and Obstetric Pathology. Book; Third Edition; 2019.

Desai S, Rekhi B, Jambhekar M. editors. Grossing of surgical oncology specimens, a complete guide towards complete pathology reporting, Pubblished by Department of Pathology, Tata memorial hospital, Mumbai; 2011.

Movahedi-Lankarani S, Blake Gilks C, Otis C, Christopher NO, Soslow R, Oliva E. Protocol for the examination of specimens from patients with carcinoma of the endometrium, college of American pathologists, AJCC/UICC TNM 7th edition and FIGO 2014 annual report; 2016.

Kurman RJ, Carcangiu Ml, Herrington Cs, Young RH, WHO Classification of tumors of the female reproductive organs. 4th ed, France: IARC Press; 2014.

Kurman RJ, Ellensosn LH, Ronnett BM, (eds), Blaustein’s Pathology of the Female Genital tract, 6 th edition, Springer Science + Business media LLC; 2011.

N’Dah KJ, Doukoure B, Troh E, Aman NA, Koffi, KE, Kouame AD, Epidemiological and histological aspects of women genital cancers in cote d’ Ivoire. Open Journal of Obstetrics and Gynacelogy. 2014;4:516-23.

Krissi H, Chetrit A, Menczer J. Presenting symptoms of patients with endometrial carcinoma. Effect on prognosis. Eur J Gynaecol Oncol. 1996;17(1):25-8.

Tanvir I, Riaz S, Hussain A, Mehboob R, Shams MU, Khan HA. Hospital based study of epithelial malignancies of endometrial cancer frequency in Lahore, Pakistan and common diagnostic pitfalls. Pathology Research International. 2014:5.

Murray SK, Clement PB, Young RH. Endometrioid carcinomas of the uterine corpus with sex cord like formations, hyalinization, and other unusual morphologic features: A report of 31 cases of a neoplasm that may be confused with carcinosarcoma and other uterine neoplasms. Am J Surg Pathol. 2005;29:157-66.

Jia M, Sun PL, Gao H. uterine lesions with sex cord -like architecture, a systematic review. Diagnostic Pathology. 2019;14:129

Ali A, Black D, Soslow RA. Difficulties in assessing the depth of myometrial invasion in endometrial carcinoma; Int J Gynecol Pathol. 2007;26(2):115-2.

Mateva S, Nikolova M & Yordanov A. Patterns of myometrial invasion in endometrial adenocarcinoma with emphasizing on microcystic, elongated and fragmented (MELF) glands pattern: a narrative review of the literature. Diagnostics. 2021;11:1707.

Mazur MT, Kurman RJ; Diagnosis of endometrial Biopsies and Curretings. Second edition, Springer; 2005.

Salman MC, Usubutun A, Boynukalin K, Yuce K. Comparison of WHO and endometrial intraepithelial neoplasia classifications in predicting the presence of coexistent malignancy in endometrial hyperplasia. J Gynecol Oncol. 2010;21:97-101.

Mittal K, Soslow R, McCluggage WG. Application of immunohistochemistry to gynecologic pathology; Arch Pathol Lab Med. 2008;132:402-23.

Salama A, Arafa M, ElZahaf E, Shebl AM, EI-Hameed Awad AA, Ashamallah AA, et al. Potential role for a panel of Immunohistochemical markers in the management of endometrial carcinoma. Journal of Pathology and Translational Medicine. 2019;53:164-72.

Kaspar HG, Crum PC, The utility of immunohistochemistry in the differential diagnosis of Gynecologic disorders. Arch Pathol Lab Med. 2015;139:39-54.

Zaino RJ, Kurman RJ, Brunetto VL, Morrow CP, Bentley RC, Capelleri JO, et al. Villoglandular Adenocarcinoma of the endometrium: a clinicopathologic study of 61 cases: a gynaecologic oncology group study. Am J Surg Pathol. 1998;22:1379-85.

Sherman ME, Bitterman P, Rosenshein NB, Delgado G, Kurman RJ. Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathological features. Am J Surg Pathol. 1992;16;600-10.






Original Research Articles